FLEURY S.A.

Public Company CNPJ nº 60.840.055/0001-31

NIRE nº 35.300.197.534

Change in Management

São Paulo, January 29th, 2018 - In order to update its shareholders and the market in general, Fleury S.A. ("Company") hereby informs the approval and appointment, on this date, by the Board of Directors of Dr. Jeane Mike Tsutsui, previously Medical, Technical and Process Executive Officer, for the position of Fleury Brand Executive Officer.

The Company also hereby informs the approval and appointment by the Board of Directors of Dr. Edgar Gil Rizzati, previously Clinical Analysis Director, for the position of Medical, Technical and Process Executive Officer.

A brief profile of the two executive officers is available on our website:www.fleury.com.br/ir.

VIVIANE BEHAR DE CASTRO

Investors Relations Officer

Fleury SA published this content on 29 January 2018 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 29 January 2018 21:08:25 UTC.

Original documenthttp://ri.fleury.com.br/fleury/web/download_arquivos.asp?id_arquivo=51AF46B8-9007-44ED-A33D-93E165F61C29

Public permalinkhttp://www.publicnow.com/view/6E39BC2CE881B7966A9631D1AE56DBFECBF92EFB